Registry Study for Talimogene Laherparepvec

NCT02173171 · clinicaltrials.gov ↗

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial

Interventions

OTHER: Information collection

Sponsor

Amgen